Tatva Chintan Pharma

972.20
+4.75
(0.49%)
Market Cap (₹ Cr.)
₹2,274
52 Week High
1,650.85
Book Value
₹315
52 Week Low
932.25
PE Ratio
87.26
PB Ratio
3.08
PE for Sector
52.01
PB for Sector
3.76
ROE
8.84 %
ROCE
9.62 %
Dividend Yield
0.21 %
EPS
₹11.14
Industry
Chemicals
Sector
Chemicals
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-6.60 %
Net Income Growth
-33.27 %
Cash Flow Change
252.92 %
ROE
-53.39 %
ROCE
-19.22 %
EBITDA Margin (Avg.)
22.21 %

Financial Results

Quarterly Financials
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
52
60
77
107
109
119
107
103
88
86
115
120
107
93
87
98
95
Expenses
40
53
53
80
81
82
79
80
73
75
97
108
86
72
74
80
86
EBITDA
12
8
24
26
28
37
28
23
15
11
18
13
21
22
14
19
9
Operating Profit %
23 %
10 %
31 %
23 %
25 %
29 %
22 %
22 %
16 %
11 %
15 %
10 %
18 %
22 %
14 %
15 %
8 %
Depreciation
2
2
2
2
2
2
2
2
2
2
2
3
6
7
7
6
7
Interest
1
1
1
1
1
1
1
1
1
2
2
3
3
3
0
0
0
Profit Before Tax
10
5
21
23
25
34
25
20
12
7
13
7
12
12
7
12
2
Tax
2
3
2
4
4
6
5
4
3
1
2
-4
2
2
1
2
0
Net Profit
8
3
20
20
24
31
22
19
9
5
11
16
8
8
5
8
2
EPS in ₹
4.04
1.45
9.94
10.13
11.93
14.24
10.12
8.52
3.83
2.37
4.76
7.29
3.72
3.63
1.99
3.52
0.64

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
145
187
245
310
676
755
815
Fixed Assets
57
67
111
120
160
196
427
Current Assets
77
114
128
178
453
308
294
Capital Work in Progress
10
6
5
10
51
231
77
Investments
1
1
1
1
1
1
11
Other Assets
76
114
129
179
464
327
301
Total Liabilities
85
108
131
148
207
250
89
Current Liabilities
63
73
87
117
194
245
87
Non Current Liabilities
22
35
44
31
14
5
2
Total Equity
59
80
114
162
469
505
726
Reserve & Surplus
51
72
106
142
447
483
702
Share Capital
8
8
8
20
22
22
23

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-10
8
-6
-6
58
-40
13
Investing Activities
-30
-17
-40
-21
-197
-101
-121
Operating Activities
13
8
25
19
20
24
103
Financing Activities
7
17
10
-5
235
38
31

Share Holding

% Holding
Jul 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
75.02 %
72.02 %
72.02 %
72.02 %
72.02 %
FIIs
3.89 %
3.53 %
2.91 %
3.05 %
3.53 %
3.59 %
3.74 %
3.54 %
3.19 %
4.13 %
4.41 %
4.21 %
3.65 %
3.37 %
DIIs
5.68 %
7.36 %
7.87 %
8.13 %
10.76 %
11.16 %
11.52 %
11.71 %
11.07 %
13.85 %
13.79 %
13.06 %
12.84 %
10.63 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.25 %
9.94 %
10.05 %
9.65 %
6.55 %
6.08 %
5.57 %
5.58 %
6.56 %
7.00 %
9.78 %
10.71 %
11.49 %
13.98 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
3,274.00 1,64,950.98 87.82 12,522.64 5.69 1,747 20.60 56.06
2,412.60 71,217.55 57.96 13,221.54 -11.53 1,336 -29.80 37.18
8,238.85 69,020.09 154.10 2,845.68 -12.16 434 13.83 59.27
4,259.40 45,861.28 134.15 4,387.74 -25.08 435 -46.27 66.00
1,204.10 40,462.25 197.95 18,096.98 1.88 595 119.92 75.12
2,839.85 38,491.48 47.78 7,757.93 -3.26 811 35.11 39.86
644.95 32,571.66 72.83 4,227.41 0.66 411 42.60 87.25
6,835.90 29,729.84 52.89 13,843.26 - 563 -46.57 54.53
1,026.45 26,032.65 34.58 15,707.00 -7.64 449 -67.63 40.19
251.50 24,396.70 27.56 5,157.76 6.53 864 3.06 39.79

Corporate Action

Technical Indicators

RSI(14)
Neutral
43.14
ATR(14)
Volatile
29.01
STOCH(9,6)
Neutral
47.74
STOCH RSI(14)
Neutral
65.64
MACD(12,26)
Bullish
2.59
ADX(14)
Weak Trend
22.29
UO(9)
Bearish
47.48
ROC(12)
Downtrend And Accelerating
-2.16
WillR(14)
Neutral
-57.46